Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.

Source:http://linkedlifedata.com/resource/pubmed/id/1846551

Download in:

View as

General Info

PMID
1846551